Nkarta to participate in upcoming investor conferences

South san francisco, calif., feb. 28, 2024 (globe newswire) -- nkarta, inc. (nasdaq: nktx), a biopharmaceutical company developing engineered natural killer (nk) cell therapies, today announced its participation in three upcoming investor conferences:

NKTX Ratings Summary

NKTX Quant Ranking